Deacon CF (2004) Circulation and degradation of GIP and GLP-1
What works for one person may not be the best fit for another, which is why we emphasize a personalized approach
The effect of glucagon-like peptide-1 and glucose dependent insulinotropic polypeptide receptor agonists on neurogenesis, differentiation, and plasticity (Neuro-GDP): potential mechanistically informed therapeutics in the treatment and prevention of mental disorders
These medications, including semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity), are increasingly prescribed in the UK for type 2 diabetes and weight management
18.2 Managing Side Effects at Home Patients can mitigate mild side effects through practical measures: Consume smaller, frequent meals Avoid high-fat foods Maintain hydration 18.3 Adherence to Weekly Injection Schedule Consistency is paramount
GLP-1 medication-induced gastroparesis is different from gastroparesis caused by permanent nerve damage